Package 0615-8008-07

{"route": ["ORAL"], "spl_id": "8763121c-ceae-4ce3-87fc-91909d586ac9", "openfda": {"unii": ["YRZ789OWMI"], "rxcui": ["617311"], "spl_set_id": ["40e6b63f-0a20-404a-8915-2f698877a96b"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "15 TABLET, FILM COATED in 1 BLISTER PACK (0615-8008-05)", "package_ndc": "0615-8008-05", "marketing_start_date": "20181106"}, {"sample": false, "description": "7 TABLET, FILM COATED in 1 BLISTER PACK (0615-8008-07)", "package_ndc": "0615-8008-07", "marketing_start_date": "20181106"}, {"sample": false, "description": "14 TABLET, FILM COATED in 1 BLISTER PACK (0615-8008-14)", "package_ndc": "0615-8008-14", "marketing_start_date": "20221213"}, {"sample": false, "description": "28 TABLET, FILM COATED in 1 BLISTER PACK (0615-8008-28)", "package_ndc": "0615-8008-28", "marketing_start_date": "20240416"}, {"sample": false, "description": "6 BLISTER PACK in 1 BOX, UNIT-DOSE (0615-8008-30)  / 5 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "0615-8008-30", "marketing_start_date": "20181112"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BLISTER PACK (0615-8008-39)", "package_ndc": "0615-8008-39", "marketing_start_date": "20181106"}], "brand_name": "ATORVASTATIN CALCIUM", "product_id": "0615-8008_8763121c-ceae-4ce3-87fc-91909d586ac9", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["HMG-CoA Reductase Inhibitor [EPC]", "Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "product_ndc": "0615-8008", "generic_name": "ATORVASTATIN CALCIUM", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ATORVASTATIN CALCIUM", "active_ingredients": [{"name": "ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE", "strength": "40 mg/1"}], "application_number": "ANDA090548", "marketing_category": "ANDA", "marketing_start_date": "20120529", "listing_expiration_date": "20261231"}